Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 178

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 178
---
 managed pharmaceutical company for which the significant employees are its officers. Code of Ethics Our Board has adopted a written code of business conduct and ethics (“Code”) that applies to our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. We intend to post on our website a current copy of the Code and all disclosures that are required by law in regard to any amendments to, or waivers from, any provision of the Code. Board Leadership Structure and Risk Oversight Our Board has responsibility for the oversight of our risk management processes and, either as a whole or through its committees, regularly discusses with management our major risk exposures, their potential impact on our business and the steps we take to manage them. The risk oversight process includes receiving regular reports from board committees and members of senior management to enable our Board to understand our risk identification, risk management, and risk mitigation strategies with respect to areas of potential material risk, including operations, finance, legal, regulatory, cybersecurity, strategic, and reputational risk. Board of Directors Our Board consists of five members. Our business and affairs are managed under the direction of our Board. Directors serve until the next annual meeting and until their successors are elected and qualified. Officers are appointed to serve until their successors have been elected and qualified. Director Independence Our Board is composed of a majority of “independent directors” as defined under the rules of Nasdaq. We use the definition of “ independence” applied by Nasdaq to make this determination. Nasdaq Listing Rule 5605(a)(2) provides that an “ independent director” is a person other than an officer or employee of the company or any other individual having a relationship which, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The Nasdaq listing rules provide that a director cannot be considered independent if:

| ● | the director is, or at                                                    
 any time during the past three (3) years was, an employee of the company; |

| ● | the director or a family                                                                                                             
 member of the director accepted any compensation from the company in excess of $120,000 during any period of twelve (12) consecutive 
 months within the three (3) years preceding the independence determination (subject to certain exemptions, including, among other    
 things, compensation for board or board committee service);                                                                          |

| ● | the director or a family                                                                                                            
 member of the director is a partner in, controlling shareholder of, or